|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.940
|
Mouse |
|
|
notochord cell development
|
GO:0060035 |
1 |
0.918
|
|
|
|
membrane raft assembly
|
GO:0001765 |
3 |
0.907
|
|
|
|
positive regulation of metalloenzyme activity
|
GO:0048554 |
3 |
0.887
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.852
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.846
|
|
|
|
negative regulation of tyrosine phosphorylation of stat5 protein
|
GO:0042524 |
2 |
0.813
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.743
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.727
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.716
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.704
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.691
|
|
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
0 |
0.688
|
|
|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.674
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.666
|
|
|
|
negative regulation of tyrosine phosphorylation of stat protein
|
GO:0042532 |
3 |
0.635
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.634
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.628
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.578
|
|
|
|
regulation of smooth muscle contraction
|
GO:0006940 |
22 |
0.569
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.563
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.559
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.556
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.543
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.543
|
|
|
|
regulation of p38mapk cascade
|
GO:1900744 |
3 |
0.534
|
|
|
|
notochord cell differentiation
|
GO:0060034 |
1 |
0.530
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.508
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.507
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.493
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.486
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.484
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.477
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.471
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.467
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.459
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.456
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.444
|
|
|
|
response to ischemia
|
GO:0002931 |
14 |
0.428
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.428
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.422
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.419
|
|
|
|
cytoplasmic microtubule organization
|
GO:0031122 |
14 |
0.412
|
|
|
|
regulation of metalloenzyme activity
|
GO:0048552 |
4 |
0.398
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.394
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.394
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.393
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.393
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.389
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.384
|
|
|
|
plasma membrane repair
|
GO:0001778 |
7 |
0.378
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.376
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.374
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.367
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.365
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.357
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.354
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.354
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.353
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.353
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.348
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.348
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.346
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.341
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.340
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.339
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.339
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.337
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.336
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.332
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.316
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.315
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.305
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.302
|
Mouse |
|
|
myotube cell development
|
GO:0014904 |
60 |
0.301
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.296
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.296
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.292
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.285
|
|
|
|
membrane biogenesis
|
GO:0044091 |
12 |
0.281
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.280
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.279
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.277
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.276
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.273
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.272
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.272
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.272
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.266
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.265
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.261
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.257
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.256
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.256
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.253
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.252
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.252
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.250
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.247
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.245
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.245
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.244
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.242
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.240
|
|
|
|
nucleus localization
|
GO:0051647 |
20 |
0.236
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.235
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.234
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.233
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.232
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.230
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.227
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.226
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.226
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.224
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.223
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.223
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.221
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.219
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.215
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.214
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.214
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.213
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.212
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.209
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.209
|
|
|
|
regulation of pinocytosis
|
GO:0048548 |
1 |
0.209
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.209
|
Mouse |
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.208
|
|
|
|
negative regulation of nitric oxide synthase activity
|
GO:0051001 |
3 |
0.206
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.203
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.203
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.201
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.201
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.199
|
|
|
|
regulation of anoikis
|
GO:2000209 |
2 |
0.198
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.196
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.193
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.193
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.191
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.188
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.186
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.185
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.182
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.181
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.181
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.181
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.180
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.178
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.176
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.174
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.174
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.172
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.171
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.171
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.169
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.168
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.168
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.168
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.167
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.167
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.166
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.166
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.165
|
|
|
|
positive regulation of calcium ion transport into cytosol
|
GO:0010524 |
9 |
0.164
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.164
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.164
|
Mouse |
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.164
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.163
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.162
|
|
|
|
plasma membrane raft organization
|
GO:0044857 |
2 |
0.160
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.159
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.159
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.158
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.157
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.156
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.156
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
25 |
0.151
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.150
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.150
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.149
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.148
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.148
|
|
|
|
membrane assembly
|
GO:0071709 |
12 |
0.146
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.146
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.145
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.144
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.144
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.142
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.141
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.140
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.137
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.135
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.134
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.133
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.132
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.132
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.131
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.131
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.130
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.129
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.128
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.128
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.124
|
|
|
|
mammary gland involution
|
GO:0060056 |
9 |
0.124
|
|
|
|
negative regulation of peptidyl tyrosine phosphorylation
|
GO:0050732 |
17 |
0.122
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.122
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.119
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.118
|
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
7 |
0.118
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.117
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.117
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.117
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.116
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.115
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.115
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.115
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.114
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.114
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.113
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.112
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.111
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.111
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.111
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.110
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.110
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.109
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.109
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.109
|
Mouse |
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.109
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.108
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.107
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.105
|
Mouse |
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.105
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.105
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.104
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.103
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.102
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.102
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.101
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.101
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.101
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.100
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.100
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.100
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.100
|
Mouse |
|
|
negative regulation of endocytosis
|
GO:0045806 |
12 |
0.100
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.099
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.099
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.099
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.099
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.098
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.096
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.096
|
|
|
|
negative regulation of monooxygenase activity
|
GO:0032769 |
3 |
0.095
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.095
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.095
|
|
|
|
anoikis
|
GO:0043276 |
6 |
0.095
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.094
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.093
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.091
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.091
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.091
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.091
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.091
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.091
|
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
12 |
0.090
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.090
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.090
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.090
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.089
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.088
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.087
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.087
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.085
|
|
|
|
negative regulation of response to cytokine stimulus
|
GO:0060761 |
9 |
0.084
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.084
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.084
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.083
|
|
|
|
tyrosine phosphorylation of stat5 protein
|
GO:0042506 |
9 |
0.083
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.082
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.082
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.082
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.082
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.082
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.080
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.080
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.079
|
|
|
|
regulation of monooxygenase activity
|
GO:0032768 |
7 |
0.078
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.078
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.077
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.077
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.076
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.076
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.076
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.076
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.076
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.076
|
|
|
|
negative regulation of endothelial cell proliferation
|
GO:0001937 |
8 |
0.074
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.074
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.073
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.073
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
29 |
0.073
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.073
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.073
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.072
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.072
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.070
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.070
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.070
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.070
|
|
|
|
negative regulation of nitric oxide biosynthetic process
|
GO:0045019 |
3 |
0.070
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.069
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.068
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.068
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.068
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.067
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.067
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.067
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.067
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.067
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.066
|
|
|
|
negative regulation of muscle hypertrophy
|
GO:0014741 |
9 |
0.065
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.064
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.064
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.063
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.063
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.063
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.063
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.062
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.062
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.062
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.062
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.062
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.061
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.061
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.061
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.060
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.060
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.060
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.060
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.060
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.059
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.059
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.059
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.059
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.059
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.058
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.058
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.058
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.058
|
|
|
|
membrane raft organization
|
GO:0031579 |
5 |
0.057
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.056
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.056
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.055
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.055
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.055
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.055
|
|
|
|
negative regulation of protein modification by small protein conjugation or removal
|
GO:1903321 |
20 |
0.054
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.054
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.054
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.053
|
|
|
|
lactation
|
GO:0007595 |
25 |
0.053
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.053
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.052
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.052
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.052
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.051
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.051
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.051
|
Mouse |
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.051
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.051
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.050
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.050
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.050
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.050
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.050
|
|
|
|
cellular response to hyperoxia
|
GO:0071455 |
1 |
0.049
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.049
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.049
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.049
|
|
|
|
syncytiotrophoblast cell differentiation involved in labyrinthine layer development
|
GO:0060715 |
2 |
0.048
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.048
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.048
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.048
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.048
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.048
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.048
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.047
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.047
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.047
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.047
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.047
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.046
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.046
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.046
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.046
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.046
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.046
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.045
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.045
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.045
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.045
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.045
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.045
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.044
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.044
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.044
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.044
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.044
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.044
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.044
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.044
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.044
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.043
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.043
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.043
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.043
|
|
|
|
negative regulation of calcium ion transport
|
GO:0051926 |
9 |
0.043
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.043
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.043
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.043
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.042
|
|
|
|
regulation of the force of heart contraction by chemical signal
|
GO:0003057 |
5 |
0.042
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.042
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.042
|
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
19 |
0.042
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.042
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.042
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.042
|
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.041
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.041
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.041
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.041
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.041
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.041
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.040
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.040
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.040
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.040
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.040
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.040
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.040
|
|
|
|
ventral trunk neural crest cell migration
|
GO:0036486 |
4 |
0.040
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.039
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.039
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.039
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.039
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.039
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.039
|
|
|
|
regulation of muscle hypertrophy
|
GO:0014743 |
13 |
0.039
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.039
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.039
|
|
|
|
regulation of branching involved in mammary gland duct morphogenesis
|
GO:0060762 |
6 |
0.039
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.039
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.038
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.038
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.038
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.038
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.038
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.038
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.038
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
10 |
0.038
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.038
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.038
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.038
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.038
|
|
|
|
negative regulation of oxidoreductase activity
|
GO:0051354 |
4 |
0.038
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.038
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.037
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.037
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.037
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.037
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.037
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.037
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.036
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.036
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
38 |
0.036
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.036
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.036
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.035
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.035
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.035
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.035
|
|
|
|
pinocytosis
|
GO:0006907 |
6 |
0.035
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
20 |
0.035
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.035
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.035
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.035
|
|
|
|
regulation of cardiac muscle hypertrophy
|
GO:0010611 |
13 |
0.034
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.034
|
|
